Indraprastha Medical Corporation Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The healthcare company, operating under the Apollo Hospitals brand in Delhi, reported steady operational performance during the period under review.

Financial Performance Overview

The company's financial results for Q3FY26 show total income from operations of ₹378.76 crore, compared to ₹330.06 crore in the corresponding quarter of the previous year. Net profit after tax for the quarter stood at ₹41.00 crore, representing an increase from ₹32.81 crore in Q3FY25.

Nine-Month Performance

For the nine-month period ended December 31, 2025, Indraprastha Medical Corporation achieved total income from operations of ₹1159.12 crore, marking growth from ₹1038.91 crore in the corresponding period of the previous year. The company's net profit after tax for the nine-month period reached ₹141.92 crore, compared to ₹119.98 crore in the same period last year.

Earnings and Capital Structure

The company's earnings per share for Q3FY26 stood at ₹4.47, while the nine-month EPS reached ₹15.48. The paid-up equity share capital remained stable at ₹91.67 crore with a face value of ₹10 per share. Total comprehensive income for the nine-month period was ₹144.38 crore.

Board Approval and Compliance

The financial results were approved by the Board of Directors and are in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has published the results in Financial Express and Jansatta newspapers as per regulatory requirements. Complete financial results are available on stock exchange websites and the company's official website.

The results demonstrate the company's continued operational stability in the healthcare sector, with consistent revenue generation and profitability across both quarterly and nine-month periods.

Indraprastha Medical Corporation Limited , which operates Indraprastha Apollo Hospitals, has reported significant growth in its financial performance for the second quarter. The company's results show strong improvements across key metrics, reflecting positively on its operational efficiency and market position.

Financial Highlights

The key financial highlights for Indraprastha Medical Corp's Q2 performance are as follows:

The company's revenue increased to ₹3.80 billion from ₹3.50 billion in the same quarter last year. EBITDA rose to ₹713.00 million from ₹636.00 million year-over-year, with the EBITDA margin improving to 18.72% compared to 18.19% in the previous year's corresponding quarter. Net profit grew to ₹494.60 crore, up from ₹424.00 crore, marking a substantial year-on-year growth of 16.60%.

Company Overview

Indraprastha Medical Corporation Limited, operating under the brand name Indraprastha Apollo Hospitals, is a key player in the Indian healthcare sector. The company is known for providing high-quality medical services and has a strong presence in Delhi-NCR.

Board Meeting and Results Approval

According to the latest corporate filing, the company's Board of Directors met to approve the unaudited financial results for the quarter ended September 30. The board meeting, which commenced at 3:00 p.m. and concluded at 4:15 p.m., also included a review of the Limited Review Report provided by the statutory auditors.

Investor Implications

The robust growth across revenue, EBITDA, and net profit is a positive indicator for investors and stakeholders. It suggests that Indraprastha Medical Corp is effectively managing its operations and potentially benefiting from increased demand for healthcare services.

While the company has shown impressive growth, it's important for investors to consider this performance in the context of broader market trends and the healthcare sector's overall performance.

Investors are advised to conduct their own research and consider multiple factors before making investment decisions.